4.5 Review

Positron emission tomography imaging in cardiovascular disease

Journal

HEART
Volume 106, Issue 22, Pages 1712-1718

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/heartjnl-2019-315183

Keywords

-

Funding

  1. Wellcome Trust Clinical Research Career Development Fellowship [211100/Z/18/Z]
  2. National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC)
  3. Cambridge British Heart Foundation (BHF) Centre for Research Excellence
  4. NIHR Cambridge BRC
  5. BHF
  6. Higher Education Funding Council for England
  7. Engineering and Physical Sciences Research Council
  8. Wellcome Trust
  9. Wellcome Trust [211100/Z/18/Z] Funding Source: Wellcome Trust
  10. EPSRC [EP/N014588/1] Funding Source: UKRI

Ask authors/readers for more resources

Positron emission tomography (PET) imaging is useful in cardiovascular disease across several areas, from assessment of myocardial perfusion and viability, to highlighting atherosclerotic plaque activity and measuring the extent of cardiac innervation in heart failure. Other important roles of PET have emerged in prosthetic valve endocarditis, implanted device infection, infiltrative cardiomyopathies, aortic stenosis and cardio-oncology. Advances in scanner technology, including hybrid PET/MRI and total body PET imaging, as well as the development of novel PET tracers and cardiac-specific postprocessing techniques using artificial intelligence will undoubtedly continue to progress the field.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available